{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:51:20Z","timestamp":1792270280010,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00296-021-05055-3","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T09:02:36Z","timestamp":1637830956000},"page":"825-829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-045X","authenticated-orcid":false,"given":"Elodie","family":"Portier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-6229","authenticated-orcid":false,"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-1986","authenticated-orcid":false,"given":"Anna","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"5055_CR1","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76:978\u2013991. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210770","journal-title":"Ann Rheum Dis"},{"key":"5055_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M et al (2014) Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 73:6\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203419","journal-title":"Ann Rheum Dis"},{"key":"5055_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102398","volume":"110","author":"M Dougados","year":"2020","unstructured":"Dougados M (2020) Treat to target in axial spondyloarthritis: from its concept to its implementation. J Autoimmun 110:102398. https:\/\/doi.org\/10.1016\/j.jaut.2019.102398","journal-title":"J Autoimmun"},{"key":"5055_CR4","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","volume":"73","author":"S Ramiro","year":"2014","unstructured":"Ramiro S, van der Heijde D, van Tubergen A et al (2014) Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 73:1455\u20131461. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205178","journal-title":"Ann Rheum Dis"},{"key":"5055_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","volume":"77","author":"C Molnar","year":"2018","unstructured":"Molnar C, Scherer A, Baraliakos X et al (2018) TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 77:63\u201369. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211544","journal-title":"Ann Rheum Dis"},{"key":"5055_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/BOR.0000000000000625","volume":"31","author":"PM Machado","year":"2019","unstructured":"Machado PM, Deodhar A (2019) Treat-to-target in axial spondyloarthritis: gold standard or fools\u2019 gold? Curr Opin Rheumatol 31:344\u2013348. https:\/\/doi.org\/10.1097\/BOR.0000000000000625","journal-title":"Curr Opin Rheumatol"},{"key":"5055_CR7","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1136\/annrheumdis-2016-209209","volume":"75","author":"D Poddubnyy","year":"2016","unstructured":"Poddubnyy D, Protopopov M, Haibel H et al (2016) High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Ann Rheum Dis 75:2114\u20132118. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209209","journal-title":"Ann Rheum Dis"},{"key":"5055_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/annrheumdis-2013-203860","volume":"73","author":"MM Schoels","year":"2014","unstructured":"Schoels MM, Braun J, Dougados M et al (2014) Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis 73:238\u2013242. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203860","journal-title":"Ann Rheum Dis"},{"key":"5055_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.rdc.2019.07.003","volume":"45","author":"E Nikiphorou","year":"2019","unstructured":"Nikiphorou E, Baraliakos X (2019) Treat to target in axial spondyloarthritis. Rheum Dis Clin N Am 45:519\u2013535. https:\/\/doi.org\/10.1016\/j.rdc.2019.07.003","journal-title":"Rheum Dis Clin N Am"},{"key":"5055_CR10","first-page":"851","volume":"33","author":"H Che","year":"2015","unstructured":"Che H, Etcheto A, Dernis E et al (2015) Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER network. Clin Exp Rheumatol 33:851\u2013857","journal-title":"Clin Exp Rheumatol"},{"key":"5055_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.semarthrit.2020.05.012","volume":"50","author":"A Molto","year":"2020","unstructured":"Molto A, Gossec L, Poiraudeau S et al (2020) Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: the results of the COMEDSPA prospective, controlled, one year randomized trial. Semin Arthritis Rheum 50:701\u2013708. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.012","journal-title":"Semin Arthritis Rheum"},{"key":"5055_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/annrheumdis-2019-216034","volume":"79","author":"U Kiltz","year":"2020","unstructured":"Kiltz U, Landew\u00e9 RBM, van der Heijde D et al (2020) Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. Ann Rheum Dis 79:193\u2013201. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216034","journal-title":"Ann Rheum Dis"},{"key":"5055_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jbspin.2020.04.019","volume":"87","author":"A Baillet","year":"2020","unstructured":"Baillet A, Romand X, Pflimlin A et al (2020) Data to be collected for an optimal management of axial spondyloarthritis in daily practice: proposal from evidence-based and consensual approaches. Jt Bone Spine 87:405\u2013411. https:\/\/doi.org\/10.1016\/j.jbspin.2020.04.019","journal-title":"Jt Bone Spine"},{"key":"5055_CR14","doi-asserted-by":"crossref","unstructured":"Gutermann L, Dumas S, Lopez-Medina C et al (2020) Impact of a pharmacist-led programme on biologics knowledge and adherence in patients with spondyloarthritis. Clin Exp Rheumatol","DOI":"10.55563\/clinexprheumatol\/pzc5lo"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-05055-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T06:59:26Z","timestamp":1673852366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-05055-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5055"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-05055-3","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests regarding this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval information"}}]}}